AnalystsDebanjana ChatterjeeDebanjana Chatterjee's Stock Forecasts
AnalystsDebanjana Chatterjee
Sectors:
Industries:
Analyst Ranking
Top 30%
#1541 out of 5208 analysts
Average Return
+21.37%
Win Rate
83%10 out of 12
Risk vs Reward
Poor
Good
Debanjana Chatterjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Contineum Therapeutics IncCTNM | +97.48% | $7.14 | $14.10 | 2025-03-13 - 2026-03-03 | Strong Buy |
Armata Pharmaceuticals IncARMP | +78.90% | $6.35 | $11.36 | 2026-01-05 - 2026-03-03 | Strong Buy |
Sionna Therapeutics IncSION | +57.68% | $21.62 | $34.09 | 2025-09-08 - 2026-03-03 | Strong Buy |
Spyre Therapeutics IncSYRE | +39.81% | $28.66 | $40.07 | 2025-12-01 - 2026-03-03 | Strong Buy |
Theravance Biopharma IncTBPH | +31.70% | $10.60 | $13.96 | 2025-06-17 - 2026-03-03 | Strong Buy |
Debanjana Chatterjee Analyst Color
Get additional color on Debanjana Chatterjee's coverage of popular stocks
Debanjana Chatterjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Armata Pharmaceuticals IncARMP | 1 | Strong Buy | $15.00 | +32.04% | Initiates Coverage On | 2 months ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $64.00 | +59.72% | Upgrades | 3 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $46.00 | +34.94% | Initiates Coverage On | 6 months ago |
Theravance Biopharma IncTBPH | 1 | Strong Buy | $24.00 | +71.92% | Initiates Coverage On | 9 months ago |
Sagimet Biosciences IncSGMT | 2 | Strong Buy | $27.00 | +380.43% | Maintains | 9 months ago |
Tvardi Therapeutics IncTVRD | 1 | Strong Buy | $39.00 | +889.85% | Initiates Coverage On | 10 months ago |
Kalvista Pharmaceuticals IncKALV | 2 | Strong Buy | $30.00 | +92.18% | Maintains | a year ago |
Contineum Therapeutics IncCTNM | 1 | Strong Buy | $23.00 | +63.12% | Initiates Coverage On | a year ago |
Pharvaris NvPHVS | 1 | Strong Buy | $46.00 | N/A | Initiates Coverage On | a year ago |
Intellia Therapeutics IncNTLA | 1 | Strong Buy | $41.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.